AG
Aaron Gal Bernstein Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Gilead Sciences
GILD
$143B
| $115.05 | $105 |
9%
downside
| Outperform | 10 months ago |
|
2 |
2
AbbVie
ABBV
$375B
| $212.56 | $203 |
5%
downside
| Market Perform | 10 months ago |
|
3 |
3
Amgen
AMGN
$153B
| $283.64 | $380 |
34%
upside
| Outperform | 10 months ago |
|
4 |
4
Regeneron Pharmaceuticals
REGN
$60.8B
| $573.38 | $1,125 |
96%
upside
| Outperform | 1 year ago |
|
5 |
5
Biogen
BIIB
$20.6B
| $140.67 | $500 |
255%
upside
| Outperform | 4 years ago |
|
6 |
6
Viatris
VTRS
$12.2B
| $10.50 | $21 |
100%
upside
| Market Perform | 4 years ago |
|